![](/img/cover-not-exists.png)
PMU47 ORPHAN DRUG DESIGNATION: NO IMPACT ON P&R PROCESS TIMING IN ITALY
Enrici, A., Lidonnici, D., Isernia, M., Lanati, E.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1666
Date:
November, 2019
File:
PDF, 368 KB
2019